{
  "id": 12731723,
  "title": "Clover Health Medicare Advantage CEO Jamie Reynoso sells $9,287 in stock",
  "url": "https://urgent.news/2026/10/07/clover-health-medicare-advantage-ceo-jamie-reynoso-sells-9-287-in",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-07T22:46:00.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/clover-health-medicare-advantage-ceo-jamie-reynoso-sells-9287-in-stock-93CH-4937679"
  },
  "original_language": "en",
  "account": "Clover Health Investments CEO Jamie L. Reynoso sold 2,006 shares of the company's Class A Common Stock on October 7, 2026. The sale amounted to $9,287, with the shares being sold at prices between $4.54 and $4.72 per share. Clover Health shares have experienced a 140% increase over the past six months, according to InvestingPro data, although the stock is currently trading above its fair value estimate and is listed as one of the most overvalued stocks on the platform. The CEO's stock sale was conducted under a pre-established Rule 10b5-1 trading plan that was implemented on March 12, 2026. After executing this transaction, Reynoso's direct ownership of Clover Health Class A Common Stock stands at 2,792,690 shares. For a more detailed analysis of CLOV's valuation and performance metrics, including 8 additional InvestingPro Tips and comprehensive Pro Research Reports, readers can refer to the platform's in-depth examination. Additionally, Clover Health reported impressive financial results for the second quarter of 2026, surpassing Wall Street's expectations. The company reported adjusted earnings of 5 cents per share, beating the anticipated 4 cents per share. Revenue for the quarter hit $743.2 million, surpassing the forecasted $728.27 million and marking a 56% increase compared to the previous year. Following these results, Clover Health has raised its full-year outlook. These positive developments highlight a favorable trend for the company, as demonstrated by the market reaction following the earnings announcement.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Truist reiterates Buy on Americold stock, lifts earnings estimates",
        "url": "https://urgent.news/2026/10/06/truist-reiterates-buy-on-americold-stock-lifts-earnings-estimates",
        "published": "2026-10-06T10:07:02.000Z"
      },
      {
        "outlet": "PE Hub",
        "title": "CD&R and McKesson ink $5.8bn take-private deal for Option Care Health",
        "url": "https://urgent.news/2026/10/06/cd-r-and-mckesson-ink-5-8bn-take-private-deal-for-option-care-health",
        "published": "2026-10-06T14:17:20.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}